June 1, 2020Journal of the American College of Cardiology117 citationsOpen Access
View Full PaperRenal Denervation in High-Risk Patients With Hypertension
Structured PICO
Does renal denervation reduce blood pressure consistently across varying high-risk comorbidities and ASCVD risk scores in patients with hypertension?
P
Population
High-risk patients with hypertension
I
Intervention
Renal denervation (RDN)
O
Outcome
Blood pressure (BP) reductionsurrogate
Renal denervation provides consistent blood pressure reduction across varying levels of baseline ASCVD risk and comorbidities in hypertensive patients.
Abstract
BP reduction after RDN was similar for patients with varying high-risk comorbidities and across the range of ASCVD risk scores. The impact of baseline risk on clinical event reduction by RDN-induced BP changes could be evaluated in further studies. (Global proSpective registrY for syMPathetic renaL denervatIon in seleCted IndicatIons Through 3 Years Registry; NCT01534299).